Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
EVENTS
VirginiaDrugDiscoveryRx: CoronaVirus Therapeutics, Present and Future
Virtual Symposium- May 26 – 27, 2021
KEYNOTE talks from leaders in COVID-19 therapeutics discovery and future, FREE or minimal registration costs for all attendees
POSTER SESSION INFORMATION
SPEAKER VIDEO PRESENTATIONS
NEWS
Webster Santos, Virginia Tech drug researcher receives $2.2 million NIH grant to further develop “fat burning” molecule
The Santos lab will use the grant to take his prototype molecules and synthesize derivatives to enhance their effectiveness in treating NASH (nonalcoholic steatohepatitis), which is characterized by inflammation, fat accumulation, and scarring of the liver. Read more...
VaDDC Executive Committee Member, Beth Sharlow Receives Promotion at UVA
Dr. Elizabeth Sharlow has been promoted to Professor of Research in Pharmacology effective July 1, 2020. More about Dr. Sharlow
Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs
A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to make the active ingredients for more than a dozen medicines used to treat patients with COVID-19. And the ingredients will be made at a pharmaceutical plant in...
AFFILIATES
Want to work with us?
If you are interested in supporting this initiative, please contact us.